Trabecular Bone Score, a new tool to predict fracture risk
There is no doubt that DXA bone densitometry has a significant impact on the diagnosis of osteoporosis. While the measurement of BMD is important in the diagnosis of osteoporosis, it has its own limitations. BMD alone cannot identify all patients…
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members
GENEVA--Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of Directors, effective immediately. Meinhard F. Schmidt, an international MedTech/BioTech and Digital Health executive with 25+ years…
TBS Osteo, The Missing Link To Bone Fracture Risk Prediction
BMD is currently the gold standard for the diagnosis of osteoporosis, but clinicians need more information to make an accurate assessment of their patients' level of fracture risk and whether to recommend treatment. TBS Osteo is an advanced imaging software…
RSNA Innovation Theater – Rethinking How To Diagnose Osteoporosis
At RSNA 2022, Dr. Lynn Kohlmeier, MD, Director of Spokane Osteoporosis and Endocrine Associates of Spokane, gave a presentation on rethinking how to diagnose osteoporosis and the use of Trabecular Bone Score (TBS). Today’s current technology for diagnosing osteoporosis only…
Book a meeting with Medimaps Group at the 2022 Santa Fe Bone Symposium
Join Medimaps Group (booth #101) at the 2022 Santa Fe Bone Symposium to talk about the NEW reimbursement for Trabecular Bone Score (TBS) and how TBS Osteo has been shown to help identify 30% more patients at risk of fracture.* * The…